ProPublica looks at the Rx-$ nexus

Share this article:

Non-profit journo outfit ProPublica found that at least 17 of the top 20 prescribers of beta blocker Bystolic in Medicare's prescription drug program in 2010 had also been paid by Forest for promotional talks.

Nine of the top 10 prescribers of Alzheimer's drug Exelon received money from Novartis, and eight of the top 10 for J&J painkiller Nucynta were paid speakers, as were six of the top 10 for Pfizer antidepressant Pristiq.

The data used came from the Dollars for Docs tool, which includes payments from 15 drug makers, as well as its new ­Prescriber Checkup, which has data on prescribing in Medicare Part D.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.